HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/4/C1094    most recent 00173.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Weiss, R. G. Articles by Dirksen, R. T. Search for Related Content PubMed PubMed Citation Articles by Weiss, R. G. Articles by Dirksen, R. T.

RECEPTORS AND SIGNAL TRANSDUCTION

Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling

Departments of ¹Biochemical Pharmacology and ³Physiology, Innsbruck Medical University, A-6020 Innsbruck, Austria; ²Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642; and ⁴Department of Anesthesia Research, Brigham and Women’s Hospital, Boston, Massachusetts 02115

Submitted 1 April 2004 ; accepted in final form 8 June 2004

Malignant hyperthermia (MH) is an inherited pharmacogenetic disorder caused by mutations in the skeletal muscle ryanodine receptor (RyR1) and the dihydropyridine receptor (DHPR) _1S-subunit. We characterized the effects of an MH mutation in the DHPR cytoplasmic III-IV loop of _1S (R1086H) on DHPR-RyR1 coupling after reconstitution in dysgenic (_1S null) myotubes. Compared with wild-type _1S, caffeine-activated Ca²⁺ release occurred at approximately fivefold lower concentrations in nonexpressing and R1086H-expressing myotubes. Although maximal voltage-gated Ca²⁺ release was similar in _1S- and R1086H-expressing myotubes, the voltage dependence of Ca²⁺ release was shifted 5 mV to more negative potentials in R1086H-expressing myotubes. Our results demonstrate that _1S functions as a negative allosteric modulator of release channel activation by caffeine/voltage and that the R1086H MH mutation in the intracellular III-IV linker disrupts this negative regulatory influence. Moreover, a low caffeine concentration (2 mM) caused a similar shift in voltage dependence of Ca²⁺ release in _1S- and R1086H-expressing myotubes. Compared with _1S-expressing myotubes, maximal L channel conductance (G_max) was reduced in R1086H-expressing myotubes (_1S 130 ± 10.2, R1086H 88 ± 6.8 nS/nF; P < 0.05). The decrease in G_max did not result from a change in retrograde coupling with RyR1 as maximal conductance-charge movement ratio (G_max/Q_max) was similar in _1S- and R1086H-expressing myotubes and a similar decrease in G_max was observed for an analogous mutation engineered into the cardiac L channel (R1217H). In addition, both R1086H and R1217H DHPRs targeted normally and colocalized with RyR1 in sarcoplasmic reticulum (SR)-sarcolemmal junctions. These results indicate that the R1086H MH mutation in _1S enhances RyR1 sensitivity to activation by both endogenous (voltage sensor) and exogenous (caffeine) activators.

excitation-contraction coupling; calcium channel; muscle disease

This article has been cited by other articles:

				R. A. Bannister, S. Papadopoulos, C. S. Haarmann, and K. G. Beam Effects of inserting fluorescent proteins into the {alpha}1S II-III loop: insights into excitation-contraction coupling J. Gen. Physiol., July 1, 2009; 134(1): 35 - 51. [Abstract] [Full Text] [PDF]

				M. Dainese, M. Quarta, A. D. Lyfenko, C. Paolini, M. Canato, C. Reggiani, R. T. Dirksen, and F. Protasi Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice FASEB J, June 1, 2009; 23(6): 1710 - 1720. [Abstract] [Full Text] [PDF]

				I. Sato, S. Wu, M. C. A. Ibarra, Y. K. Hayashi, H. Fujita, M. Tojo, S. J. Oh, I. Nonaka, S. Noguchi, and I. Nishino Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation Neurology, January 8, 2008; 70(2): 114 - 122. [Abstract] [Full Text] [PDF]

				T. Yang, E. Esteve, I. N. Pessah, T. F. Molinski, P. D. Allen, and J. R. Lopez Elevated resting [Ca2+]i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1591 - C1598. [Abstract] [Full Text] [PDF]

				J. Zhou, J. Yi, L. Royer, B. S. Launikonis, A. Gonzalez, J. Garcia, and E. Rios A probable role of dihydropyridine receptors in repression of Ca2+ sparks demonstrated in cultured mammalian muscle Am J Physiol Cell Physiol, February 1, 2006; 290(2): C539 - C553. [Abstract] [Full Text] [PDF]

				R. S. Litman and H. Rosenberg Malignant Hyperthermia: Update on Susceptibility Testing JAMA, June 15, 2005; 293(23): 2918 - 2924. [Abstract] [Full Text] [PDF]